Citius Pharmaceuticals Inc. [NASDAQ: CTXR] loss 0.00% or 0.0 points to close at $1.04 with a heavy trading volume of 1067330 shares.
It opened the trading session at $1.09, the shares rose to $1.09 and dropped to $1.03, the range by which the price of stock traded the whole day. The daily chart for CTXR points out that the company has recorded 26.83% gains over the past six months. However, it is still -160.0% lower than its most recent low trading price.
If we look at the average trading volume of 1.68M shares, CTXR reached to a volume of 1067330 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Citius Pharmaceuticals Inc. [CTXR]:
The Average True Range (ATR) for Citius Pharmaceuticals Inc. is set at 0.07 The Price to Book ratio for the last quarter was 1.51, with the Price to Cash per share for the same quarter was set at 0.16.
Trading performance analysis for CTXR stock
Citius Pharmaceuticals Inc. [CTXR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.97. With this latest performance, CTXR shares gained by 11.83% in over the last four-week period, additionally plugging by 26.83% over the last 6 months – not to mention a rise of 35.08% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CTXR stock in for the last two-week period is set at 51.32, with the RSI for the last a single of trading hit 55.65, and the three-weeks RSI is set at 50.75 for Citius Pharmaceuticals Inc. [CTXR]. The present Moving Average for the last 50 days of trading for this stock 1.0782, while it was recorded at 1.0180 for the last single week of trading, and 0.9444 for the last 200 days.
Citius Pharmaceuticals Inc. [CTXR]: A deeper dive into fundamental analysis
Return on Total Capital for CTXR is now -59.32, given the latest momentum, and Return on Invested Capital for the company is -59.57. Return on Equity for this stock declined to -59.57, with Return on Assets sitting at -51.84. When it comes to the capital structure of this company, Citius Pharmaceuticals Inc. [CTXR] has a Total Debt to Total Equity ratio set at 0.71. Additionally, CTXR Total Debt to Total Capital is recorded at 0.70, with Total Debt to Total Assets ending up at 0.60.
Reflecting on the efficiency of the workforce at the company, Citius Pharmaceuticals Inc. [CTXR] managed to generate an average of -$1,729,127 per employee.Citius Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.40 and a Current Ratio set at 2.40.
Citius Pharmaceuticals Inc. [CTXR]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Citius Pharmaceuticals Inc. posted -0.16/share EPS, while the average EPS was predicted by analysts to be reported at -0.14/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -14.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CTXR.
An analysis of insider ownership at Citius Pharmaceuticals Inc. [CTXR]
There are presently around $1 million, or 13.00% of CTXR stock, in the hands of institutional investors. The top three institutional holders of CTXR stocks are: VANGUARD GROUP INC with ownership of 539,349, which is approximately 16.137% of the company’s market cap and around 39.08% of the total institutional ownership; ARGENT WEALTH MANAGEMENT LLC, holding 164,444 shares of the stock with an approximate value of $0.17 million in CTXR stocks shares; and VIRTU FINANCIAL LLC, currently with $95000.0 in CTXR stock with ownership of nearly New of the company’s market capitalization.
Positions in Citius Pharmaceuticals Inc. stocks held by institutional investors increased at the end of September and at the time of the September reporting period, where 10 institutional holders increased their position in Citius Pharmaceuticals Inc. [NASDAQ:CTXR] by around 308,623 shares. Additionally, 5 investors decreased positions by around 1,476,045 shares, while 3 investors held positions by with 814,669 shares. The mentioned changes placed institutional holdings at 969,999 shares, according to the latest SEC report filing. CTXR stock had 7 new institutional investments in for a total of 212,575 shares, while 4 institutional investors sold positions of 1,459,575 shares during the same period.